课题基金 / 基金详情

Pathology and Molecular Evolution of HTLV in Asia

Pathology and Molecular Evolution of HTLV in Asia
亚洲 HTLV 的病理学和分子进化
批准号:
07042008
负责人:
OSAME Mitsuhiro
金额:
$10.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

OSAME Mitsuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this resesrch is to clarify the HTLV/STLV infection in Asia and we conducted the molecular epidemiological search and analyzed pathogenic relations of HLA.1) STLV-I positive cases were newly detected on 3 orangutans and 1 gibbon in Indonesia. Genetic analysis showed STLV-I of orangutan was quite variable and made two clusters in phylogenetictree. It is not likely that Melanesian group of HTLV-I directly came from orangutan although the group belongs to big Asian STLV-I group. 2) Seroscreening for HTLV-I was carried out in India (400 blood donors in Kelara, 20 HAM/TSP patients in karnataka), Malaysia (50 donors in Kelantan, Northern Malaysia) , Thailand (20 T-lymphoma patients in Songkhula, Southern Thailand) and Indonesia (220 Iryanese, Inryan Jaya). HTLV was not endemic among none of the ethnic groups tested. 3) In order to study molecular phylogenetic relationships among the HTLV isolates, genomic DNAs were extracted from lymphocytes of seropositive subjects in India, Andra Pradesh, and used as templates in PCR studies. provirus genome was detected in two independent families in Andra Pradesh. The lymphocytes were cultured in the presence of IL-2. After six months in culture, cells expressing HTLV specific antigens showed proliferation. 4) About 200 samples from Pakistan and Afghanistan including minority of mountain area, about 900 samples from Azerbaijan, and about 900 samples from Altai were screened and resulted in all negative for HTLV-I.5) HLA typing of HAM/TSP patients from Mashhadi Jews showed high prevalence of B52 type, supporting the important relations of the tupe to HTLV-I pathogenesis.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
M. Saito: "Mutation Rates in LTR of HTLV-I in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence" Journal of Neuro Virology. 2. 330-335 (1996)
M. Saito:“HAM/TSP 患者和携带者中 HTLV-I LTR 的突变率与 Tax/Rex 编码序列的突变率相似”《神经病毒学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
G. Picchio: "HTLV-I/II Indeterminate Sevology and Natural Killer Cell Expansion" Journal of AIDS and Human Retro virology. 12. 428-431 (1996)
G. Picchio:“HTLV-I/II 不确定信号学和自然杀伤细胞扩增”艾滋病和人类逆转录病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Gurtsevitch,V.,Hayami,M.,et al.: "HTLV-1 infection among Nivkhi people in Sakhalin." Int.J.Cancer. 60. 432-433 (1995)
Gurtsevitch,V.,Hayami,M.,et al.:“萨哈林岛尼夫赫人中的 HTLV-1 感染。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ibuki, K., et al: "Isolation of STLV-I from orangutan, a great ape species in southeast Asia, and its relation to other HTLV-Is/STLV-Is" Jpn J Cancer Res. 88. 1-4 (1997)
Ibuki, K. 等人:“从东南亚的一种类人猿猩猩中分离出 STLV-I,及其与其他 HTLV-Is/STLV-Is 的关系”Jpn J Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    Exploitation of new therapies for HTLV-I-assotiated myelopathy
    • 批准号:
      14207031
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.71万
    • 财政年份:
      2002
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    HAMの臨床病態・発症機序の解明並びに新治療法の開発に関する研究
    • 批准号:
      11470146
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      1999
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)
    • 批准号:
      09470155
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.26万
    • 财政年份:
      1997
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    Epidemiology and pathology of human retrovirus infection
    • 批准号:
      06042013
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $3.26万
    • 财政年份:
      1994
    • 负责人:
      OSAME Mitsuhiro
    • 依托单位:
    国内基金
    海外基金
    pH响应型靶向ATL@Fe-MOF@M纳米载体在胆囊癌双模式成像指导下光热/化学动力协同免疫治疗的研究
    遗传性感觉神经病中ATL3突变致轴索末梢内质网功能障碍的机制研究
    • 批准号:
      LZ23H090004
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      赵国华
    • 依托单位:
    拟南芥E3泛素连接酶ATL5调控种子寿命的作用机制研究
    • 批准号:
      32070349
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      陈喜文
    • 依托单位:
    拟南芥E3泛素连接酶ATL17调控脱落酸抑制主根生长的分子机制研究
    • 批准号:
      31870248
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2018
    • 负责人:
      郝福顺
    • 依托单位: